Mpm Asset Management LLC Adaptimmune Therapeutics PLC Transaction History
Mpm Asset Management LLC
- $43.3 Million
- Q2 2025
A detailed history of Mpm Asset Management LLC transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Mpm Asset Management LLC holds 4,809,677 shares of ADAP stock, worth $673,354. This represents 2.66% of its overall portfolio holdings.
Number of Shares
4,809,677
Previous 5,335,715
9.86%
Holding current value
$673,354
Previous $1.07 Million
8.15%
% of portfolio
2.66%
Previous 1.54%
Shares
4 transactions
Others Institutions Holding ADAP
# of Institutions
70Shares Held
116MCall Options Held
10.3KPut Options Held
0-
Eco R1 Capital, LLC San Francisco, CA27.4MShares$3.84 Million0.57% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR23.8MShares$3.33 Million0.26% of portfolio
-
Two Seas Capital LP Rye, NY22.6MShares$3.16 Million0.1% of portfolio
-
Nea Management Company, LLC Timonium, MD17.1MShares$2.39 Million0.34% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.41MShares$617,6540.21% of portfolio
About Adaptimmune Therapeutics PLC
- Ticker ADAP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 163,370,000
- Market Cap $22.9M
- Description
- Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...